CannaPharmaRX, Inc. Share Price Other OTC
Equities
CPMD
US13765D1090
Pharmaceuticals
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.57M 204M |
---|---|---|---|---|---|
Net income 2021 | -8M -635M | Net income 2022 | -8M -635M | EV / Sales 2021 | - |
Net Debt 2021 | 8.99M 714M | Net Debt 2022 | 14.52M 1.15B | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.11
x | P/E ratio 2022 |
-0.25
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.33% |
Managers | Title | Age | Since |
---|---|---|---|
Dean Medwid
CEO | Chief Executive Officer | - | 31/05/23 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 31/12/16 |
Oliver Foeste
DFI | Director of Finance/CFO | 48 | 12/10/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Orman
CHM | Chairman | 74 | 22/04/19 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 31/12/16 |
Anthony Panek
BRD | Director/Board Member | 39 | 24/08/23 |
1st Jan change | Capi. | |
---|---|---|
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |